GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?

E-ISSN： 1873-4294|10|8|799-813

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.8, 2010-06, pp. : 799-813

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor

Current Medicinal Chemistry, Vol. 17, Iss. 14, 2010-05 ,pp. : 1411-1429

Bentham Science Publishers

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Advances in the Physiology of GPR55 in the Central Nervous System

Current Neuropharmacology, Vol. 15, Iss. 5, 2017-06 ,pp. : 771-778

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid receptor agonists and antagonists

By Barth F.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. : 301-313

Informa Healthcare

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite